- Targeted stakeholdersIdentify insurance coverage gaps for pain control during gynecologic procedures, enabling targeted policy or payer inte…
- Targeted stakeholdersInform evidence-based administrative or legislative changes to improve access to pain management in women's health.
- Targeted stakeholdersReveal provider training or resource shortages that could be addressed through education or funding programs.
Gynecologic Pain Management Study Act
Referred to the House Committee on Energy and Commerce.
The bill directs the HHS Secretary to conduct a comprehensive study on barriers to providers offering and patients accessing pain management methods during gynecologic procedures.
It requires stakeholder consultation, a literature review and potential new research, and a report with findings and recommendations to two congressional committees within 24 months.
Content is narrow, administrative, and low-cost; such study bills often advance, though timing and any reproductive-policy framing create uncertainty.
Relative to its intended legislative type, this bill is a straightforward, clearly purposed congressional directive for the Secretary of HHS to conduct a study and report on barriers to pain management during gynecologic procedures. It establishes responsible authority, stakeholder consultation, and a firm reporting deadline, but remains high-level regarding methods, resources, legal integration, and safeguards.
Liberals prioritize equity and immediate follow-up action.
Who stands to gain, and who may push back.
- Federal agenciesRequires federal funding or reallocation, increasing budgetary demands on HHS or Congress.
- Targeted stakeholdersStudy recommendations could prompt regulatory or insurance mandates that raise provider administrative or compliance co…
- Targeted stakeholdersMay duplicate existing literature or programs, producing redundant analysis without new actionable results.
Why the argument around this bill splits.
Liberals prioritize equity and immediate follow-up action.
Likely strongly supportive.
Views the study as a necessary step to document gaps in pain care and health equity during gynecologic procedures.
Would expect the study to center patient voices and recommend policy fixes to improve access.
Generally favorable but pragmatic.
Sees value in evidence-gathering before policy changes, while wanting clear budget, timeline, and impartiality.
Will judge the bill on study quality and actionable recommendations.
Mixed to somewhat skeptical.
Views the bill as federal study expansion that could create administrative costs and precedent for further regulation.
Some may accept a narrowly scoped study but worry about politicized scope, including any links to abortion care.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrow, administrative, and low-cost; such study bills often advance, though timing and any reproductive-policy framing create uncertainty.
- No explicit funding or appropriation authorization included
- Whether "gynecologic procedures" will be politically framed around abortion
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals prioritize equity and immediate follow-up action.
Content is narrow, administrative, and low-cost; such study bills often advance, though timing and any reproductive-policy framing create u…
Relative to its intended legislative type, this bill is a straightforward, clearly purposed congressional directive for the Secretary of HHS to conduct a study and report on barriers to pain management during gynecologi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.